MedPath

The Effect of Chlorella on Glycemic Control of Diabetes

Not Applicable
Conditions
Diabetes
Interventions
Drug: Chlorella
Registration Number
NCT01301287
Lead Sponsor
Cardinal Tien Hospital
Brief Summary

Chlorella, a type of unicellular fresh water algae, has been a popular foodstuff in Asia, especially in Taiwan. Recent studies have shown the hypoglycemic effects of Chlorella through increasing glucose uptake in the liver and muscle, lowering serum free fatty acid levels, or activation of PPAR gamma receptor. However, the hypoglycemic effect in diabetic patients have not been studied. In order to clarify the hypoglycemic effects and mechanism of Chlorella in diabetic patients, the investigators conducted a 12-week randomized, double-blind, placebo-control trial on diabetic patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 18-70 years old
  • type 2 diabetes with less than 2 kinds of oral antidiabetes drugs
  • Hba1c: 7.0-9.0
Exclusion Criteria
  • type 1 diabetes
  • pregnancy
  • acute infectious disease
  • autoimmune disease
  • hemodynamic unstable

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ChlorellaChlorella-
Primary Outcome Measures
NameTimeMethod
HbA1c12 weeks
Secondary Outcome Measures
NameTimeMethod
Insulin concentration during oral glucose tolerance test12 weeks

All subjects received the first oral glucose tolerance test before intervention(week 0), and the second oral glucose tolerance test on week 12.

Trial Locations

Locations (1)

Cardinal Tien Hospital

🇨🇳

New Taipei City, Taiwan

© Copyright 2025. All Rights Reserved by MedPath